Krakow, Poland – September 15, 2017 – Selvita, one of the largest drug discovery companies in Europe, has published semiannual financial results. In H1 2017 Selvita Group recognized total operating revenues (incl. grants) of PLN 59.7 MM, which means a 109% increase compared to H1 2016 when the operating revenues…
Selvita exhibits at ChemOutsourcing
Krakow, 28 August 2017 – Selvita will participate and exhibit at the upcoming Pharma ChemOutsourcing 2017 conference, which will take place 18 – 20 September 2017, in Ocean Place Resort, Long Branch, NJ. ChemOutsourcing is the largest USA-based API show attracting annually 700-800 chemists and business development personnel from the pharmaceutical,…
Selvita will exhibit at 19th RSC/SCI Medicinal Chemistry Symposium
Kraków, Poland – 24 August 2017 – Selvita will participate in and exhibit at the upcoming 19th RSC/SCI Medicinal Chemistry Symposium which will take place on 10 – 13 September 2017, in Cambridge, UK. Reflecting current trends in medicinal chemistry and pharmaceutical research, the scientific programme of the conference will feature…
Selvita and The Leukemia & Lymphoma Society Announce Partnership to Advance SEL120 into Phase I for AML Patients
Krakow, Poland, and Rye Brook, NY, USA —August 08, 2017 – Selvita S.A. (WSE: SLV) and The Leukemia & Lymphoma Society (LLS) announced today a partnership to co-fund further preclinical and clinical development of a targeted therapy to treat patients with acute myeloid leukemia (AML). Selvita has discovered and is…
Institute of Hematology and Transfusion Medicine and Selvita publish joint research results in SEL24 project
Krakow, Poland – July 13, 2017 – Institute of Hematology and Transfusion Medicine, the leading Polish hematology and blood transfusion institute, jointly with Selvita, a clinical stage drug discovery and development company focused on innovative medicines for oncology patients, have published results of a research projects concerning therapeutic potential of…
Selvita presents at 18th Drug Discovery Summit in Berlin
Krakow, Poland – 06 June 2017 – Selvita is a proud sponsor of the upcoming 18th Drug Discovery Summit which will take place on June 12 – 13, 2017, in Berlin, Germany. This event will gather over 250 delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions,…